USA
Analytical Standards
Controlled Research Environment
Research Product
IGF-1 DES
1. Product Overview
IGF-1 DES is a truncated analogue of Insulin-Like Growth Factor-1 (IGF-1) that has attracted significant scientific interest in research involving cellular signaling, growth factor biology, tissue response mechanisms, and receptor-mediated pathways. Ongoing studies have explored its interaction with IGF-1 receptors and its role in cellular growth, differentiation, and regenerative biological processes. IGF-1 DES is supplied as a lyophilized research peptide and undergoes analytical testing to verify identity, purity, and consistency.
Manufactured in a controlled research environment, this product is intended exclusively for laboratory and scientific research applications.
2. Specifications
| Product Name | IGF-1 DES | Testing Method | HPLC |
|---|---|---|---|
| Synonym | IGF-1 DES (1-3) | Storage Condition | 2-8C |
| Format | Lyophilized Powder | Shelf Life | 24 Months |
| Content | 1 mg per vial | Manufacturing Standard | GMP Standard Research Environment |
| Purity | >=99% HPLC | Country of Origin | USA |
| Appearance | White to Off White Lyophilized Powder | Intended Use | Research Use Only |
3. Research Summary
IGF-1 DES (IGF-1 DES 1-3) is a truncated analogue of Insulin-Like Growth Factor-1 (IGF-1) that has attracted significant scientific interest in studies involving growth factor signaling, cellular proliferation, tissue response mechanisms, receptor-mediated pathways, and regenerative biology. Research has explored its interaction with IGF-1 receptors and its influence on cellular communication networks involved in growth and development.
Preclinical investigations have examined the role of IGF-1 DES in cellular differentiation, protein synthesis pathways, tissue remodeling, and growth factor-mediated biological processes. Ongoing laboratory studies continue to evaluate its activity within IGF-related signaling networks and cellular adaptation mechanisms.
4. Scientific References
- Tomas FM, Knowles SE, Owens PC, Read LC, Chandler CS, Gargosky SE, Ballard FJ. Insulin-like growth factor-I and its truncated analogues in growth factor signaling research. Biochemical Journal. 1992;282(1):91-97.
- Gillespie CM, Busby WH Jr, Ma J, Clemmons DR. Dissociation of Insulin-Like Growth Factor-I from IGF-binding proteins by truncated IGF analogues. Endocrinology. 1990;127(2):549-554.
- Francis GL, Aplin SE, Milner SJ, McNeil KA, Ballard FJ, Wallace JC. Insulin-like growth factor-I analogues and receptor interactions. Biochemical Journal. 1993;293(3):713-719.
- LeRoith D, Bondy C, Yakar S, Liu JL, Butler A. The Somatomedin Hypothesis: Growth hormone and IGF-I biology. Endocrine Reviews. 2001;22(1):53-74.
- Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Reviews. 1995;16(1):3-34.
Disclaimer: This product is intended strictly for research use only. It is not intended for human consumption, clinical application, diagnostic procedures, therapeutic use, veterinary use, or household use. The information provided is for scientific and educational reference purposes only and should not be interpreted as medical advice, treatment guidance, or usage instructions. This product should be handled only by qualified professionals trained in laboratory practices. Purchasers and end users are solely responsible for ensuring compliance with all applicable laws, regulations, and institutional requirements governing the purchase, storage, handling, and use of research materials.
